Tech Company Financing Transactions
AllStripes Funding Round
AllStripes closed a $50 million Series B funding round on 8/25/2021. Investors included Lux Capital, private investors and JAZZ Venture Partners.
Transaction Overview
Company Name
Announced On
8/25/2021
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to: launch 100 new rare disease research programs; expand global operational presence, technology and data automation enhancements to improve research insights, develop the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continue to invest in growing the team to support creating the playbook for rare disease research.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
121 2nd St. 700
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Overview
AllStripes' mission is to unlock new treatments for people with rare disease. About 1 in 10 people have a rare disease, and half are children. AllStripes (formerly RDMD) was co-founded in 2017 by CEO Nancy Yu and Onno Faber, a rare disease patient deeply frustrated by the drug development process.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/25/2021: Armored Things venture capital transaction
Next: 8/25/2021: CapShift venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs